Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial

Perry B. Shieh, Salvador Rico, Martin K. Childers et al.|The Lancet Neurology|2023

Cited by 120